Monday, February 16, 2015 6:28:11 PM
http://www.google.com/finance?cid=672714
Recent GENE News
- Join Genetic Technology’s Exclusive Live Investor Webinar and Q&A Session on October 2 • GlobeNewswire Inc. • 09/23/2024 12:30:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/11/2024 01:47:59 PM
- Genetic Technologies Invited to Join Prestigious “CancerIQ” Online Platform - Provides Access to 45 Healthcare Systems and 250 Clinics • GlobeNewswire Inc. • 09/11/2024 12:15:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/28/2024 12:15:07 PM
- Genetic Technologies Announces Global Launch of geneType™ on Wholly Owned EasyDNA platform • GlobeNewswire Inc. • 08/15/2024 12:00:00 PM
- Join Genetic Technology’s Exclusive Live Investor Webinar and Q&A Session on August 15 • GlobeNewswire Inc. • 08/09/2024 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 07/31/2024 12:00:33 PM
- Genetic Technologies Strategic Restructure Driving USA Sales Growth • GlobeNewswire Inc. • 07/26/2024 12:00:00 PM
- Genetic Technologies Announces Appointment of Chief Financial Officer & Company Secretary • GlobeNewswire Inc. • 07/16/2024 12:00:00 PM
- GeneType to Enter Canadian and New Zealand Markets • GlobeNewswire Inc. • 07/09/2024 12:00:00 PM
- GeneType Identifies 79.5% of People Tested are at Risk of Serious Disease • GlobeNewswire Inc. • 06/25/2024 12:00:00 PM
- Join Genetic Technologies’ Exclusive Live Investor Webinar and Q&A Session on June 27 • GlobeNewswire Inc. • 06/21/2024 12:00:00 PM
- Genetic Technologies Expands Operational Capacity in North America • GlobeNewswire Inc. • 06/18/2024 12:00:00 PM
- GeneType and Stayhealthy Announce Landmark Distribution Agreement for Revolutionary Multi-Risk Test • GlobeNewswire Inc. • 06/05/2024 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 06/05/2024 10:10:06 AM
- GTG Launches Revolutionary geneType Test covering 100% Risk of Breast and Ovarian Cancer • GlobeNewswire Inc. • 05/29/2024 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/29/2024 10:05:16 AM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 05/28/2024 04:15:13 AM
- GeneType and Humanise Health host “Know Your Risk” Event • GlobeNewswire Inc. • 05/23/2024 12:00:00 PM
- GTG and ‘Wellworks for You’ sign B2B sales & marketing deal covering 750 employer groups and 2 million U.S. employees • GlobeNewswire Inc. • 05/06/2024 12:00:00 PM
- Genetic Technologies Announces Closing of US$2 Million Registered Direct Offering • GlobeNewswire Inc. • 04/22/2024 07:00:36 PM
- Genetic Technologies Announces $2 Million Registered Direct Offering • GlobeNewswire Inc. • 04/18/2024 04:17:51 PM
- New Precision Oncology Tests to Drive Personalised Therapies and Improved Treatment Outcomes • GlobeNewswire Inc. • 04/17/2024 12:00:00 PM
- GeneType Clinicians’ Adoption Growing - Sales up 5-Fold Year on Year • GlobeNewswire Inc. • 04/16/2024 12:00:00 PM
- GTG to pilot GeneType in Breast Screen centers across the U.S. • GlobeNewswire Inc. • 04/11/2024 12:00:00 PM
SANUWAVE Announces Reverse Stock Split, Note and Warrant Exchange, and PIPE Offering • SNWV • Oct 18, 2024 9:31 AM
Vocodia Addresses Recent Stock Price Movement and Future Strategic Partnerships • VHAI • Oct 18, 2024 9:00 AM
Mass Megawatts Announces the Start of an Online Discount Solar Energy Equipment Business with Revenue Recognized for the First Time Since Year 2010 in this Fiscal Quarter • MMMW • Oct 18, 2024 7:32 AM
Unitronix Corp Advances DeFi Innovation with Tokenized Real-World Assets Integration • UTRX • Oct 17, 2024 7:38 AM
Mass Megawatts Commences Solar Energy Sales Efforts • MMMW • Oct 16, 2024 7:45 AM
SANUWAVE Health Announces 1-For-375 Reverse Stock Split • SNWV • Oct 16, 2024 7:40 AM